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Abstract
Aberrant apoptosis of airway epithelial cells (AECs) is a disease contributing
feature in the airways of asthmatics. The proinflammatory cytokines tumor
necrosis factor a (TNFa) and interferon c (IFNc) are increased in asthma and
have been shown to contribute to apoptosis at the airways. In the present
study, we investigated the role of the inhibitor of apoptosis protein (IAP)
family in primary AECs exposed to TNFa and IFNc. IAPs are potent regula-
tors of caspase activity elicited by the intrinsic and extrinsic apoptosis path-
ways. However, while caspase-mediated apoptosis was observed in AECs
exposed to doxorubicin, it was not observed after cytokine treatment. Instead,
AECs exhibited proapoptotic changes evidenced by an increased Bax:Bcl2 tran-
script ratio and partial processing of procaspase-3. Examination by quantita-
tive reverse transcription polymerase chain reaction (qRT-PCR) and Western
analysis showed that proapoptotic changes were associated with a time- and
dose-dependent induction of cellular IAP-2 (cIAP2), potentiated primarily by
IFNc. The abundance of the IAP antagonists X-linked IAP-associated factor 1
(XAF1) and second mitochondria-derived activator of caspases did not
change, although a moderate nuclear redistribution was observed for XAF1,
which was also observed for cIAP2. Small interfering RNA (siRNA)-mediated
depletion of cIAP2 from AECs leads to caspase-3 activation and poly (ADP-
ribose) polymerase cleavage, but this required extended cytokine exposure to
produce a concomitant decrease in cIAP1 and Bcl2. These results indicate that
AECs possess endogenous mechanisms making them highly resistant to apop-
tosis due to asthma-related inflammatory cytokines, and the activity of cIAP2
plays an important role in this protection.
Introduction
The primary function of the airway epithelium (AE) is to
maintain the airways for efficient ventilation. Central to
this, the AE possess a remarkable regenerative capacity,
with most airway epithelial cells (AECs) able to function as
stem cells (Crystal et al. 2008). In asthma, the AE exhibits
a fragile phenotype and inefficient repair after injury, a
phenomenon hypothesized to sustain focused areas of AEC
activation (Holgate 2011). Prolonged activation of AECs
disrupts the epithelial barrier and leads to inappropriate
secretion of immunomodulatory cytokines and growth
factors (Holgate 2011; Lambrecht and Hammad 2012).
The concept of a chronically injured epithelium has been
convincingly linked with the unifying signs of asthma, such
as Th2-related bronchial hyperreactivity, infiltration of
inflammatory cells, and airway remodeling (Davies 2009;
Bartemes and Kita 2012; Lambrecht and Hammad 2012).
Consequently, dysregulation of the mechanisms regulating
AEC apoptosis may significantly impact epithelial fragility
and repair, and contribute to the disease.
The airways of asthmatics exhibit an elevated rate of
epithelial apoptosis (Zhou et al. 2011), a phenomenon
which increases with disease severity (Cohen et al. 2007).
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Conversely, infiltrating inflammatory cells are resistant to
death in asthmatics (de Souza and Lindsay 2005), pro-
longing the release of factors such as transforming growth
factor b (TGF-b), tumor necrosis factor a (TNFa), Fas
ligand, and interleukin 1b (IL-1b), which can elicit apop-
tosis of AECs (Trautmann et al. 2002; Nakamura et al.
2004; Makinde et al. 2007; White 2011). However, apop-
tosis of AECs in asthmatics has been observed in the
absence of prolonged inflammation, and demonstrate
abnormalities for the production of Bcl2 and activation of
caspases (Cohen et al. 2007; Holgate 2011; Zhou et al.
2011). Other factors shown to promote apoptosis of the
AE include dysregulated zinc homeostasis (Roscioli et al.
2013), decreased production of E-cadherin (Trautmann
et al. 2005), and heightened sensitivity to disease-related
agents such as Fas ligand (White 2011). Whether elevated
AEC apoptosis potentiates the fragile AE phenotype, or is
a distinct phenomenon, remains unclear (White 2011).
Further to this, less is known about the function of
endogenous suppressors of the caspase cascade in the
inflamed airways, and whether they exhibit deficits which
may explain the aberrant apoptosis.
Members of the inhibitor of apoptosis protein (IAP)
family are best known for their capacity to inhibit caspases;
however, they also participate in other prosurvival activities
(Roscioli et al. 2013). Of the IAPs, X-linked IAP (XIAP),
cellular IAP-1 (cIAP1), and cIAP2, have been examined
most rigorously due to their ubiquitous expression and
association with cancer (Fulda and Vucic 2012). XIAP in
particular is noted to inhibit caspase-3, -7, and -9, while
some contention exists whether cIAP1 and cIAP2 inhibit
caspases directly (Eckelman and Salvesen 2006). A more
likely scenario is that multiple IAPs are required to main-
tain the apoptotic threshold (Moulin et al. 2012), and
employ overlapping mechanisms to inhibit caspase activity.
XIAP and the cIAPs have also gained significant attention
through their involvement in a number of aspects of the
immune response, including the regulation of the inflam-
masome and nuclear factor-kappa beta (NF-jB) signaling
(Gyrd-Hansen and Meier 2010; Beug et al. 2012). Given
the fragile nature of the AE in asthmatics, and the signifi-
cant apoptotic pressure posed by the inflammation, dys-
function of the IAPs may have significant consequences for
the integrity of the AE.
Here, we use primary AEC cultures stimulated with
TNFa and interferon c (IFNc) to determine whether dys-
regulation of XIAP, cIAP1, and cIAP2 contributes to
apoptosis observed in asthma-related inflammation.
Although TNFa and IFNc are pleiotropic cytokines which
can influence several downstream pathways, their eleva-
tion in the airways of asthmatics has been shown to
potentiate apoptosis of AECs (e.g., Trautmann et al. 2002,
2005). We hypothesize that apoptosis of AECs, at least in
part, occurs through the reduction in IAP expression and
function, or the upregulation of the IAP antagonists sec-
ond mitochondrial-derived activator of caspases (Smac)
and XIAP-associated factor 1 (XAF1).
Experimental Procedures
Human samples
Asthmatic (n = 10, five females, median age 50 years)
and control subjects (n = 10, five females, median age
34 years) were selected from individuals attending clinics
at the Queen Elizabeth Hospital and Lyell McEwin Hospi-
tal (Adelaide, Australia). Asthma status was based on self-
report and previous diagnosis of asthma by a clinician.
Asthmatic subjects exhibited mild-to-moderate, persistent
form of the disease, and either did not require asthma
medication, or used b2-receptor agonists (60%). Control
volunteers were selected with no previous history of
asthma and other respiratory diseases. Participants were
free of conditions of the nasal cavity, and did not report
a history of allergic rhinitis. This study was approved by
The Queen Elizabeth Hospital and Lyell McEwin Hospital
Ethics of Human Research Committee, and was con-
ducted in accordance with the Declaration of Helsinki.
Primary AEC culture
Informed consent was obtained prior to collection of
AEC via nasal brushing. Nasal AECs were used as they
are easily accessed, and do not require the donor to be
sedated. In addition, nasal AECs exhibit comparable mor-
phology to bronchial epithelial cells, and respond simi-
larly in the context airway inflammation (McDougall
et al. 2008). AECs were suspended in Bronchial Epithelial
Growth Media (BEGM, Lonza, Walkersville, MD), and
subject to monocyte depletion using anti-CD68 (Dako,
Glostrup, Denmark) coated flasks for 20 min, in routine
cell culture conditions (37°C, humidified, 5% CO2). Cells
were expanded using type I collagen-coated flasks
(Thermo Fisher, Waltham, MA), in BEGM. TNFa, IFNc,
and doxorubicin (all Sigma-Aldrich, St. Louis, MO) were
used as treatment agents in AEC cultures. Cell cultures
were confirmed to be of epithelial linage by professional
cytologists (IMVS Cytology Department, The Queen Eliz-
abeth Hospital, Adelaide, Australia), via reactivity to
PAN-cytokeratin versus CD45 antibodies, and morpho-
logical examination via Diff-Quick analysis.
Quantitative RT polymerase chain reaction
RNA was extracted from AEC cultures using the RNeasy
RNA isolation method (Qiagen Valencia, CA). Comple-
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mentary DNA (cDNA) was generated using MMLV
reverse transcriptase (Invitrogen, Carlsbad, CA) and ran-
dom hexamer RNA primers (Qiagen), and quantitative
RT polymerase chain reaction (qRT-PCR) was performed
using HotStar Taq polymerase kit (Qiagen) and the syto-
9 DNA stain (Life Technologies, Carlsbad, CA). qRT-PCR
was performed using the Corbett Rotor-Gene 6000 ther-
mocycler (Qiagen), and results normalized to two endog-
enous control genes. Primers sequences, shown in
Table 1, were designed in-house and synthesized by Gene-
Works (Adelaide, Australia). All primer pairs were
assessed for the production of a single PCR product, and
reaction efficiencies exceeding 90%. Relative quantifica-
tion was performed using the ΔΔCt method.
Western analysis
Protein was extracted from AEC cultures in situ, and
Western blotting performed using the XCell SureLock
Mini Cell System (Invitrogen). Membranes were probed
with antibodies directed to b-actin (Sigma), Bcl2 (Santa
Cruz, Dallas, TX), poly (ADP-ribose) polymerase (PARP),
caspase-3, cIAP2 (both Cell Signaling, Danvers, MA),
cIAP1 (R&D Systems, Minneapolis, NE), XAF1 (AbCAM,
Cambridge, U.K.), and XIAP (BD Biosciences, San Diego,
CA). Luminescence was detected using the LAS-4000 Ima-
ger (Fugifilm, Tokyo, Japan), and densitometry analyses
performed using Multi-Gauge software (V3.0, Fugifilm
Science Lab). Log-transformed density scores were nor-
malized to both b-actin and the biological control.
Fluorescent immunocytochemistry
AECs fixed in 2.5% neutral buffered formalin were simul-
taneously probed with anti-cIAP2 goat (R&D Sytems)
and anti-XAF1 rabbit (Abcam) antibodies. Goat and rab-
bit mock immunoglobulin G (IgG) proteins were used to
control for nonspecific binding of the respective primary
antibodies. The nucleic acid stain 4′,6-diamidino-2-
phenylindole (DAPI, Sigma) was used to resolve nuclei.
Microscopy was performed using a Nikon Eclipse 90i
microscope (Nikon, Tokyo, Japan).
Apoptosis and necrosis assays
The processing of procaspase-3 and cleavage of PARP are
events associated with apoptosis. Hence, western analysis
antibodies were selected which detect both the unprocessed
and cleaved forms of procaspase-3 and PARP. In addition,
caspase-3/7 activity was detected using the FAM-FLICA flu-
orophore (ImmunoChemistry Technologies, Bloomington,
MN) which binds to the catalytic site of these caspases.
Microscopy was used to image fluorescence generate by cas-
pase-bound fluorophores. Finally, qRT-PCR was used to
determine modulation of Bax and Bcl2 transcript levels. The
relative abundance of Bax (potentiates cytochrome-c release
from mitochondria) and Bcl2 (an inhibitor of cytochrome-c
release) is an indicator of apoptotic changes (Salakou et al.
2007). Lactate dehydrogenase (LDH) released from com-
promised cells was used to quantify necrosis in cultures,
according to the manufacturer’s instructions (Cytotoxicity
Detection Kit; Roche, Penzberg, Germany). In addition,
cells grown in chamber slides were stained with propidium
iodide to assess for necrotic cells, and Hoechst was used to
resolve nuclei (both ImmunoChemistry Technologies).
Small interfering RNA knockdown of cIAP2
Prevalidated small interfering RNA (siRNA) was used to
deplete cIAP2 transcripts in primary AEC cultures. cIAP2-
specific siRNA (Qiagen, siRNA id: Hs_BIRC3_7) was trans-
fected into AECs using HiPerFect transfection reagent
(Qiagen). Scrambled siRNA oligonucleotide (AllStars Nega-
tive control siRNA; Qiagen) was used to control for non-
specific gene silencing as a result of the transfection process.
Results
Primary airway epithelia cells treated with
TNFa and IFNc demonstrate proapoptotic
changes
We first examined the apoptosis in primary AECs treated
with TNFa and IFNc. AEC from healthy donors treated
Table 1. Primers used for qRT-PCR.
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with cytokines exhibit a time- and dose-dependent increase
in Bax/Bcl2 transcripts (Fig. 1A). Assessment of cytotoxic-
ity in these cultures shows cell necrosis remained
unchanged over the treatment regime (Fig. 1B). Support-
ing a proapoptotic outcome, cytokine treatment is suffi-
cient to potentiate the generation of a 19 kDa caspase-3
subunit, however, the 17 kDa subunit was not detected
(Fig. 1C). Consequently, PARP cleavage is not observed, as
a second processing step needed to generate the caspase-3
heterodimer was inhibited or not elicited. Interestingly,
AECs treated with cytokines exhibit punctuate regions of
active caspase-3/7 within the cytoplasm, whereas doxorubi-
cin produces a nuclear and cytosolic distribution (Fig. 1D).
In agreement with results for cytotoxicity, propidium
iodide is excluded from AECs treated with the cytokines.
These results indicate primary AEC resist apoptotic stimuli
brought about by TNFa and IFNc, and may employ endog-
enous mechanisms to arrest the caspase cascade.
Figure 1. TNFa and IFNc produce proapoptotic changes in primary airway epithelial cells (AECs). Cultured primary AECs from healthy donors
were treated with TNFa and IFNc, and assessed for apoptosis and necrosis. (A) Time- and dose-dependent elevation in the Bax/Bcl2 transcript
ratio is detected, particularly after 20 h of cytokine exposure (n = 5 donor AECs). Gene expression data were baselined to the 2-h untreated
sample, and normalized to hypoxanthine phosphoribosyltransferase-1 and TATA box-binding protein reference genes. *P < 0.05; ***P < 0.001.
Error bars represent 95% confidence intervals. (B) Cultures assessed for relative Bax/Bcl2 transcript abundance were also examined for
cytotoxicity, by measuring lactate dehydrogenase release into culture media. Error bars represent 95% confidence intervals. (C) Western
analysis demonstrates procaspase-3 is partially processed in AECs treated with 50 ng/mL cytokines (single 19 kDa product). In contrast,
doxorubicin (Dox; a control for caspase-mediated apoptosis) -treated cells (1 lmol/L for 20 h) exhibit complete procaspase-3 processing (both
19 and 17 kDa products), which is associated with cleavage of poly (ADP-ribose) polymerase (PARP). Results represent experiments using three
AEC donors. (D) AECs treated with TNFa and IFNc (50 ng/mL, 20 h) were assessed via immunofluorescence for necrosis using propidium iodide
(PI), and caspase-3 localization. PI incorporation was not detected for AECs treated with proinflammatory cytokines, versus doxorubicin-treated
(1 lmol/L) cells, which appear to exhibit secondary necrosis. Cells treated with proinflammatory cytokines demonstrate punctate regions of
caspase-3 and/or -7 in the cytosol versus a more generalized and nuclear localization in doxorubicin-treated cells. Hoeschst staining was used to
resolve cell nuclei. Results are representative of experiments performed using three AEC donors.
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TNFa and IFNc elevate cIAP2 and XAF1
transcription in AECs from asthmatic and
control donors
Next, we determined whether the expression of cIAP1,
cIAP2, and XIAP, or their antagonists XAF1 and Smac,
modulate in a manner consistent with resistance to cyto-
kine-induced apoptosis. The increased Bax:Bcl2 transcript
ratio previously observed in nonasthmatics is similarly
elevated in AECs from asthmatic donors (Fig. 2). In line
with this observation, the expression of each transcript
was found to be comparable between AECs derived from
control and asthmatic participants. Although, XIAP,
cIAP1, and Smac demonstrate marginal elevation in gene
expression after 20-h cytokine treatment, cIAP2 exhibited
a considerably time- and dose-dependent increase. Inter-
estingly, an escalation in XAF1 transcription may repre-
sent a response to counter increasing levels of cIAP2.
Induction of cIAP2 by inflammatory
cytokines is associated with partial
processing of procaspase-3
We next determined whether IAP protein abundance
reflects changes observed in gene expression. As for its
transcript, XIAP protein expression remained stable over
the treatment regimen (Fig. 3A). cIAP1 protein also
remain consistent, although a nonsignificant reduction
with both cytokines (2.75-fold, P = 0.062) was observed.
Basal levels of cIAP2 were often undetected in untreated
AEC. However, exposure to IFNc or both cytokines lead
to a dose- and time-dependent induction in cIAP2,
matching XIAP and cIAP1 (Fig. 3A and B). Interestingly,
induction of cIAP2 coincides with the generation of a sin-
gle 19 kDa caspase-3 product, which is for the most part
potentiated by IFNc. Conversely, the previously observed
increase in XAF1 transcript did not produce an associated
elevation in protein abundance. Bcl2 protein levels also
remained stable, with the exception of a nonsignificant
reduction with 50 ng/mL of both cytokines (1.5-fold,
P = 0.19). Immunofluorescent analysis shows that XAF1
and cIAP2 share a uniform distribution throughout the
cytosol, and a moderate increase in nuclear localization as
a result of IFNc and combination treatment (Fig. 3C).
Doxorubicin inhibits cytokine-mediated
cIAP2 induction, and is associated with
apoptosis of AECs
While using doxorubicin to provide a positive control for
caspase-mediated apoptosis, we observed that a reduction
in cIAP1 and Bcl2 protein expression was consistent with
apoptosis (e.g., Fig 3A). Hence, to determine whether
doxorubicin also arrests cIAP2 induction, AECs were trea-
ted with doxorubicin in the presence or absence of TNFa
and IFNc. Approximately 1 lmol/L of doxorubicin
induces apoptosis in AEC after 20 h (Fig. 4). Interest-
ingly, this concentration also inhibits cytokine-mediated
cIAP2 induction, reducing its protein abundance to basal
levels. Inhibition of cIAP2 correlates with complete pro-
caspase-3 processing, and apoptosis as evidence by PARP
cleavage. Of note, the proapoptotic influence of TNFa
and IFNc did not sensitize AECs to apoptosis using doxo-
rubicin below 1 lmol/L, where cIAP2 expression remains
elevated. Consequently, basal level cIAP2 with concomi-
tant reduction in cIAP1 and Bcl2 may produce conditions
suitable for apoptosis in AECs.
Downregulation of cIAP1 and Bcl2 is
associated with cytokine-induced apoptosis
in cIAP2-depleted AECs
As cIAP2 upregulation by TNFa and IFNc correlates with
AEC survival, and this induction is inhibited by doxoru-
bicin, may indicate cIAP2 has a role in preventing apop-
tosis. To examine this, siRNA was used to knockout
cIAP2 transcripts in AECs stimulated with cytokines.
AECs depleted of cIAP2 and treated for 20 or 48 h exhib-
ited the previously observed pattern of incomplete procas-
pase-3 processing, and full-length PARP (not shown).
However, extending cytokine exposure to 72 h potenti-
ated conditions permissive to caspase-3 activation and
PARP cleavage (Fig. 5A). In the absence of cIAP2, procas-
pase-3 processing favors the generation of the 19 kDa cas-
pase-3 subunit. This may have limited the formation of
caspase-3 heterodimers, as incomplete cleavage of PARP
was a consistent observation. Unlike earlier time points,
extending cytokine exposure to 72 h caused a significant
reduction in cIAP1 and Bcl2 protein abundance (Fig 5B
and C). This suggests that apoptosis as a result of cIAP2
depletion may depend on reductions in cIAP1 and Bcl2,
which is in agreement with finding for doxorubicin-
induced AEC apoptosis.
Discussion
In this study, we report that AECs exhibit a proapoptotic
phenotype when exposed to asthma-related proinflamma-
tory cytokines, and cIAP2 in partnership with cIAP1 and
Bcl2, may be primary factors blocking commitment to
apoptosis. In comparison to other reports (e.g., Traut-
mann et al. 2002, 2005; Zheng et al. 2005; Stout et al.
2007; Basinski et al. 2009), we were unable to elicit apop-
tosis exclusively through exposure to TNFa and IFNc, a
situation which may reflect differences in cell culture
(White 2011). For example, unlike AECs cultured directly
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Figure 2. Airway epithelial cells (AECs) from asthmatic and healthy donors exposed to proinflammatory cytokines, exhibit corresponding levels
of inhibitor of apoptosis protein (IAP) transcript abundance. Cultured primary AECs from asthmatic (n = 5) and nonasthmatic (n = 5) donors
were cultured in the presence of TNFa and IFNc, and assessed for Bax/Bcl2, IAP, and IAP-antagonists transcript abundance. Gene expression
data were baselined to the 2-h untreated sample, and normalized to hypoxanthine phosphoribosyltransferase-1 and TATA box-binding protein
reference genes. *P < 0.05, **P < 0.01, and ***P < 0.001, and pertain to the combined expression data. Error bars represent 95% confidence
intervals.
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from donors, the commonly used normal human bron-
chial epithelial (NHBE) cell line can grow on a plastic
substratum, and are often examined at subconfluence.
Primary cells are more resistant to cell death, particularly
on surfaces such as collagen at densities over 85%
(Aoshiba et al. 1997; Shi et al. 2002; Leverkus et al.
Figure 3. Cellular inhibitor of apoptosis-2 protein is upregulated in response to IFNc in primary airway epithelial cells (AECs). Cultured primary
AECs from nonasthmatic donors (n = 3) were treated with TNFa and/or IFNc for 20 h, and protein expression assessed via Western analysis and
immunocytochemistry. (A) An increase in cIAP2 protein abundance in AECs treated with IFNc correlates with the production of a single 19 kDa
cleaved caspase-3 band, but not cleavage of poly (ADP-ribose) polymerase (PARP). Doxorubicin (Dox) is used as a positive control for caspase-
mediated apoptosis. (B) Densitometry analyses of Western blot results confirm a dose- and time-dependent increase in cIAP2 protein
abundance, particularly in response to IFNc. In contrast, XAF1 protein does not alter with cytokine treatment. Protein expression was baselined
to the abundance in the untreated sample, and normalized to the expression of b-actin. *P < 0.05, **P < 0.01, and ***P < 0.001, and pertain
to the cIAP2 expression data. Error bars represent 95% confidence intervals. (C) XAF1 and cIAP2 have a uniform distribution throughout the
cell, with a moderate nuclear relocalization in response to IFNc. IgG cont. refers to an isotype control antibody. 4′,6-diamidino-2-phenylindole
(DAPI) was used to resolve cell nuclei.
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2003). Hence, NHBE shedding often ascribed to TNFa-
and IFNc-related apoptosis may mask other important
cell survival mechanisms. In line with this, recently Liao
et al. (2011) found that NHBE cells are resistant to IFNc,
and targeted downregulation of apolipoprotein was
required to produce caspase-dependent apoptosis. Here,
AECs demonstrated proapoptotic changes, evidence by an
increased Bax:Bcl2 transcript ratio, and partially processed
procaspase-3 in the absence of PARP cleavage (Fig. 1A
and C). Interestingly, immunofluorescence revealed local-
ized regions of caspase activation within the cytosol of
cytokine-treated cells (Fig. 1D). As active caspases were
not detected during western analysis, this observation
may represent caspases incorporated into protein com-
plexes, or an artifact of the fluorophore associating with
partly processed procaspases. The presence of partially
cleaved procaspases without progression into apoptosis
indicates regulation by the IAPs.
The significance of IAP expression in the inflamed air-
way is yet to be explored. We found that basal levels of
XIAP and cIAP1 were high in AEC, implying a sentinel
function. Conversely, basal level cIAP2 was often below
detection, but was strongly induced by IFNc (Fig. 3A).
This suggests that the cIAPs are differentially regulated,
and cIAP2 may provide a cytoprotective function. How-
ever, investigations using the A549 AEC line demon-
strated that IFNc did not influence IAP expression, and
inhibited TNF-related apoptosis-inducing ligand-mediated
upregulation of cIAP2 (Wen et al. 1997; Park et al. 2002,
2004). Interestingly, similar IAP expression is found in
neutrophils stimulated with IFNc, which demonstrate a
moderate upregulation in cIAP2 via activation of the
JAK-STAT pathway (Sakamoto et al. 2005). In addition,
the cIAP2 promoter contains a putative binding element
for interferon regulatory transcription factor 1, which is
known to regulate several proteins involved in apoptosis
(Hong et al. 2000; Maher et al. 2007). Rat hepatocytes
treated with a TNFa and IFNc also upregulate cIAP2, but
likely as a result of TNFa/NFkB signaling (Schoemaker
et al. 2002; Peng et al. 2012). Although the cIAP2 pro-
moter contains NF-jB-responsive elements (e.g., Jin et al.
2009), TNFa potentiated a modest increase in cIAP2 in
AECs examined here. Of the IAP antagonists, a vast
increase in XAF1 transcription did not translate into ele-
vated protein abundance, suggesting influential posttrans-
lational regulation. However, XAF1 and cIAP2 were
observed to exhibit a partial relocalization from the cyto-
sol to the nucleus after stimulation with IFNc (Fig. 3D).
XAF1 is known to complex with XIAP and sequester it to
the nucleus (Liston et al. 2001). cIAP2 can also localize to
the nucleus (Mekhail et al. 2007) and is known to bind
XAF1 (Arora et al. 2007), but whether this occurs as a
proapoptotic mechanism through XAF1–cIAP2 complexes
requires further investigation. We were unable to detect
altered gene expression in AECs derived from asthmatics
versus controls (Fig. 2), which may suggest there is no
intrinsic defect in IAP regulation.
The cIAP2 induction correlated with partial processing
of procaspase-3, pointed toward cIAP2 preventing pro-
gression into apoptosis. During our use of doxorubicin,
we found that downregulation of cIAP1 and Bcl2, with
basal level cIAP2, was consistent with apoptosis (e.g.,
Fig. 3A). Further to this, induction of cIAP2 by proinflam-
matory cytokines was abolished by doxorubicin (Fig. 4),
suggesting that basal levels of cIAP2 may be a requirement
for caspase activation in primary AECs. Similarly, targeted
depletion of cIAP2 using siRNA did not result in caspase-3
activation, unless cytokine exposure was extended to
Figure 4. Doxorubicin-induced downregulation of cIAP2 correlates with airway epithelial cells (AECs) apoptosis. Cultured primary AECs were
treated for 20 h with increasing concentrations of doxorubicin (Dox), in the presence or absence of 50 ng/mL TNFa and IFNc. TNFa and IFNc
potentiate the induction of cIAP2 until doxorubicin concentration reaches 1 lmol/L, after which cIAP2 expression is inhibited and apoptosis is
detected. Results are representative of experiments using three AEC donors.
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produce a significant reduction in cIAP1 and Bcl2 (Fig. 5).
This may mean cIAP2 plays a distinct prosurvival role that
becomes apparent after the overlapping activities of cIAP1
and Bcl2 decline. These findings are consistent with other
reports which found apoptosis through reduced IAP sur-
veillance requires the depletion of more than one IAP
(Rumble et al. 2008; Moulin et al. 2012). Sensitization to
apoptosis by depleting the cIAPs, without a reduction in
XIAP, has been observed in a number of investigations
(e.g., Ruemmele et al. 2002; Kim et al. 2012). Here, cIAP2
knockout strongly favored the generation of a single cas-
pase-3 product (Fig. 5A), suggesting that cIAP2 regulates
the initial step of procaspases-3 maturation, performed by
initiator caspases. The imbalance in caspase-3 products
may have limited the formation of active caspase-3 hetero-
dimers. However, XIAP is a potent inhibitor of caspase-3
enzymatic activity, and can therefore inhibit activated
caspases which perform the final cleavage for procaspases-
3 maturation (Zorn et al. 2012). Hence, abundant XIAP in
cytokine-treated AECs was likely responsible for the imbal-
ance in procaspases-3 processing observed after cIAP2
knockdown. Indeed, convincing evidence exists that the cI-
APs do not possess the necessary residues to physically
interact with caspases in vivo (Eckelman and Salvesen
2006), and they primarily effect cell survival through alter-
native mechanisms (summarized in Roscioli et al. [2013]).
Hence, cIAP2 is no doubt an influential prosurvival factor,
but may not be sufficient to protect against apoptosis in
isolation.
Here, AECs from asthmatic and control donors pro-
duced similar IAP expression profiles when treated with
proinflammatory cytokines. Given the fragile nature of
AECs derived from asthmatics, we hypothesized that IAP
expression may be downregulated after exposure to TNFa
and IFNc. The use of air–liquid interface culture models
have been shown to emphasize asthma-associated pheno-
types exhibited by AECs during in vitro investigations
(e.g., Hackett et al. 2011, 2013). Consequently, we are
now examining the possibility of whether an air–liquid
culture system will define differences in IAP expression,
in AECs derived from asthmatics.
Our findings demonstrate that cIAP2 is a critical factor
providing resistance to AECs exposed to asthma-related
inflammation. Contemporary asthma therapies which pas-
sage the AE to target the mediators of inflammation and
bronchial constriction overlook disease-causing factors
presented by AECs. Further to this, there is strong evi-
dence that some asthma medications contribute to AE
apoptosis (Dorscheid et al. 2006). In the future, therapeu-
tics with the duel objective of preventing inflammation
and maintaining the viability of the AE may provide sig-
nificant progress toward countering the perpetuating fac-
tors associated with asthma.
Figure 5. Apoptosis of cIAP2-depleted airway epithelial cells
(AECs) by TNFa and IFNc correlates with cIAP1 and Bcl2
downregulation. (A) AECs from nonasthmatic donors were
transfected with cIAP2-specific siRNA, and cultured for 72 h in
the presence of TNFa and IFNc (50 ng/mL). A large 19 kDa
caspase-3 product is produced, with a relatively small 17 kDa
product. Transfection (Txn) reagent and scrambled siRNA (sham)
oligonucleotides were included to control for unintended cIAP2
silencing, and apoptosis as a result of transfection conditions.
Doxorubicin (Dox) was used as a positive control for caspase-
mediated apoptosis. These results are representative of
experiments performed using three AEC donors. (B) Primary AECs
treated with TNFa and IFNc for 72 h exhibit downregulation of
cIAP1 and Bcl2 protein abundance, while XIAP and XAF1 levels
remain stable. (C) Densitometry analysis of Western blots (n = 3)
shows cIAP1 and Bcl2 downregulation becomes significant when
AECs are treated with 50 ng/mL of TNFa and IFNc. Results are
representative of three experiments using different AEC donors.
Protein expression was baselined to the abundance in the
untreated sample, and normalized to the expression of b-actin.
**P < 0.01; ***P < 0.001. Error bars represent 95% confidence
intervals.
ª 2013 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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